Close Menu

A Pretty Nice Pasture

The former president of product development at Genentech, Susan Desmond-Hellmann, will be taking up a chancellor post at the University of California, San Francisco, after the Board of Regents votes on her appointment later this week, reports the WSJ Health Blog. Before joining Genentech, Desmond-Hellman trained at UCSF, then practiced as an oncologist. At Genentech, she oversaw the development of Avastin, Herceptin, and Rituxan.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.